Brief: Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., Mba, To Its Board Of Directors
08/10/2026 13:16
BRIEF-Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., Mba, To Its Board Of Directors Oct 8 (Reuters) - Aardvark Therapeutics, Inc. AARD.O:
AARDVARK THERAPEUTICS APPOINTS CLINICAL DEVELOPMENT LEADER DAVID ZHANG, PH.D., MBA, TO ITS BOARD OF DIRECTORS
Source text: ID:nGNXc1Mxkq
Further company coverage: AARD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aardvark Therapeutics
See all newsBrief: Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., Mba, To Its Board Of Directors
Aardvark Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aardvark Therapeutics Q2 operating expenses fall on paused ARD-101 clinical trials and workforce reduction
Aardvark Therapeutics, Inc. expected to post a loss of 87 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Intel, Nvidia, Aardvark